JONATHAN JAY MAZELSKY - 05 Aug 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
President and CEO, Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan Jay Mazelsky
Issuer symbol
IDXX
Transactions as of
05 Aug 2023
Net transactions value
-$85,694
Form type
4
Filing time
08 Aug 2023, 17:59:03 UTC
Previous filing
17 Jul 2023
Next filing
05 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +384 +0.53% $0.000000 73,095 05 Aug 2023 Direct F1
transaction IDXX Common Stock Tax liability $85,694 -170 -0.23% $504.08 72,925 05 Aug 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Options Exercise -384 -3.5% 10,443 05 Aug 2023 Common Stock 384 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 12 shares purchased under the Issuer's Employee Stock Purchase Plan on June 30, 2023.
F2 Closing price of Issuer common stock on NASDAQ market on August 4, 2023.
F3 Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020.
F4 Not applicable.